BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12730217)

  • 1. Rho-dependent Rho kinase activation increases CD44 surface expression and bone resorption in osteoclasts.
    Chellaiah MA; Biswas RS; Rittling SR; Denhardt DT; Hruska KA
    J Biol Chem; 2003 Aug; 278(31):29086-97. PubMed ID: 12730217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression.
    Chellaiah MA; Kizer N; Biswas R; Alvarez U; Strauss-Schoenberger J; Rifas L; Rittling SR; Denhardt DT; Hruska KA
    Mol Biol Cell; 2003 Jan; 14(1):173-89. PubMed ID: 12529435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.
    Bourguignon LY; Singleton PA; Zhu H; Diedrich F
    J Biol Chem; 2003 Aug; 278(32):29420-34. PubMed ID: 12748184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
    Desai B; Rogers MJ; Chellaiah MA
    Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration.
    Zohar R; Suzuki N; Suzuki K; Arora P; Glogauer M; McCulloch CA; Sodek J
    J Cell Physiol; 2000 Jul; 184(1):118-30. PubMed ID: 10825241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway.
    Hirao M; Sato N; Kondo T; Yonemura S; Monden M; Sasaki T; Takai Y; Tsukita S; Tsukita S
    J Cell Biol; 1996 Oct; 135(1):37-51. PubMed ID: 8858161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells.
    Bourguignon LY; Zhu H; Shao L; Zhu D; Chen YW
    Cell Motil Cytoskeleton; 1999; 43(4):269-87. PubMed ID: 10423269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion.
    Razzouk S; Brunn JC; Qin C; Tye CE; Goldberg HA; Butler WT
    Bone; 2002 Jan; 30(1):40-7. PubMed ID: 11792563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts.
    Suzuki K; Zhu B; Rittling SR; Denhardt DT; Goldberg HA; McCulloch CA; Sodek J
    J Bone Miner Res; 2002 Aug; 17(8):1486-97. PubMed ID: 12162503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration.
    Singleton PA; Bourguignon LY
    Cell Motil Cytoskeleton; 2002 Dec; 53(4):293-316. PubMed ID: 12378540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion.
    Bourguignon LY; Singleton PA; Diedrich F; Stern R; Gilad E
    J Biol Chem; 2004 Jun; 279(26):26991-7007. PubMed ID: 15090545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility.
    Chellaiah MA; Hruska KA
    Calcif Tissue Int; 2003 Mar; 72(3):197-205. PubMed ID: 12469249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of alphav beta3 integrin on human osteoclast-like cells stimulates adhesion and migration in response to osteopontin.
    Faccio R; Grano M; Colucci S; Zallone AZ; Quaranta V; Pelletier AJ
    Biochem Biophys Res Commun; 1998 Aug; 249(2):522-5. PubMed ID: 9712729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active Rho kinase (ROK-alpha ) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells.
    Begum N; Sandu OA; Ito M; Lohmann SM; Smolenski A
    J Biol Chem; 2002 Feb; 277(8):6214-22. PubMed ID: 11739394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of osteoblast differentiation by Pasteurella multocida toxin (PMT): a role for Rho GTPase in bone formation.
    Harmey D; Stenbeck G; Nobes CD; Lax AJ; Grigoriadis AE
    J Bone Miner Res; 2004 Apr; 19(4):661-70. PubMed ID: 15005854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
    Samanna V; Wei H; Ego-Osuala D; Chellaiah MA
    Exp Cell Res; 2006 Jul; 312(12):2214-30. PubMed ID: 16631740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that activation of ASIC1a by acidosis increases osteoclast migration and adhesion by modulating integrin/Pyk2/Src signaling pathway.
    Li X; Ye JX; Xu MH; Zhao MD; Yuan FL
    Osteoporos Int; 2017 Jul; 28(7):2221-2231. PubMed ID: 28462470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mediators of alphavbeta3-induced endothelial cell survival.
    Rice J; Courter DL; Giachelli CM; Scatena M
    J Vasc Res; 2006; 43(5):422-36. PubMed ID: 16888388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin-mediated signaling in the regulation of osteoclast adhesion and activation.
    Duong LT; Rodan GA
    Front Biosci; 1998 Aug; 3():d757-68. PubMed ID: 9682033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclasts resorb protein-free mineral (Osteologic discs) efficiently in the absence of osteopontin.
    Contractor T; Babiarz B; Kowalski AJ; Rittling SR; Sørensen ES; Denhardt DT
    In Vivo; 2005; 19(2):335-41. PubMed ID: 15796195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.